ASTEPRO ALLERGY Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Astepro Allergy, and what generic alternatives are available?
Astepro Allergy is a drug marketed by Bayer Hlthcare and is included in one NDA. There are three patents protecting this drug.
This drug has fifty patent family members in twenty-four countries.
The generic ingredient in ASTEPRO ALLERGY is azelastine hydrochloride. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Astepro Allergy
A generic version of ASTEPRO ALLERGY was approved as azelastine hydrochloride by APOTEX INC on April 30th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ASTEPRO ALLERGY?
- What are the global sales for ASTEPRO ALLERGY?
- What is Average Wholesale Price for ASTEPRO ALLERGY?
Summary for ASTEPRO ALLERGY
International Patents: | 50 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 5 |
Patent Applications: | 1,692 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ASTEPRO ALLERGY |
What excipients (inactive ingredients) are in ASTEPRO ALLERGY? | ASTEPRO ALLERGY excipients list |
DailyMed Link: | ASTEPRO ALLERGY at DailyMed |
![ASTEPRO ALLERGY drug patent expirations Drug patent expirations by year for ASTEPRO ALLERGY](/p/graph/s/t/ASTEPRO_ALLERGY-patent-expirations.png)
Recent Clinical Trials for ASTEPRO ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Chicago | Phase 4 |
Meda Pharmaceuticals | Phase 4 |
Novella Clinical | Phase 4 |
Pharmacology for ASTEPRO ALLERGY
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for ASTEPRO ALLERGY
ASTEPRO ALLERGY is protected by three US patents.
Patents protecting ASTEPRO ALLERGY
Compositions comprising azelastine and methods of use thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compositions comprising azelastine and methods of use thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: OTC USE: ALLERGY SYMPTOM RELIEVER; TEMPORARY RELIEF OF THESE SYMPTOMS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES: NASAL CONGESTION, RUNNY NOSE, SNEEZING AND ITCHY NOSE
Compositions comprising azelastine
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | ASTEPRO ALLERGY | azelastine hydrochloride | SPRAY, METERED;NASAL | 213872-001 | Jun 17, 2021 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bayer Hlthcare | ASTEPRO ALLERGY | azelastine hydrochloride | SPRAY, METERED;NASAL | 213872-001 | Jun 17, 2021 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Bayer Hlthcare | ASTEPRO ALLERGY | azelastine hydrochloride | SPRAY, METERED;NASAL | 213872-001 | Jun 17, 2021 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ASTEPRO ALLERGY
See the table below for patents covering ASTEPRO ALLERGY around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Africa | 200704902 | Compositions comprising azelastine and methods of use thereof | ⤷ Sign Up |
China | 101098714 | Compositions comprising azelastine and methods of use thereof | ⤷ Sign Up |
Slovenia | 2377557 | ⤷ Sign Up | |
Japan | 2008521812 | ⤷ Sign Up | |
European Patent Office | 2522365 | Compositions comprenant de l'azélastine et leurs procédés d'utilisation (Compositions comprising azelastine and methods of use thereof) | ⤷ Sign Up |
South Korea | 20180030953 | 아젤라스틴을 포함하는 조성물 및 이의 사용 방법 (COMPOSITIONS COMPRISING AZELASTINE AND METHODS OF USE THEREOF) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ASTEPRO ALLERGY
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1519731 | 13C0067 | France | ⤷ Sign Up | PRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215 |
1519731 | 92269 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
1519731 | C300740 | Netherlands | ⤷ Sign Up | PRODUCT NAME: AZELASTINE OF EEN; NAT. REGISTRATION NO/DATE: RVG114215 20141125; FIRST REGISTRATION: 2011/07125-REG 20130215 |
0316633 | 99C0012 | Belgium | ⤷ Sign Up | PRODUCT NAME: AZELASTINE HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: 31 IS 113 F 13 19981021; FIRST REGISTRATION: GB PL 08336/0083 19980218 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |